Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer Risk in Xeroderma Pigmentosum Heterozygotes

NCT00046189 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00046189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00046189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer Risk in Xeroderma Pigmentosum Heterozygotes
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
April 7, 2003
Completion date
January 5, 2024
Enrollment
301 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, melanoma, skin cancer, squamous cell carcinoma, xeroderma pigmentosum